H.C. Wainwright analyst Arthur He reiterated a Neutral rating on Prime Medicine (NASDAQ: PRME).The analyst commented: "On July 16, Prime ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE